ANI Pharmaceuticals, Inc. (ANIP)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 61.73 |
| Open | 61.61 |
| Bid | 61.52 x 100 |
| Ask | 61.79 x 200 |
| Day's Range | 61.14 - 62.46 |
| 52 Week Range | 44.27 - 70.81 |
| Volume | |
| Avg. Volume | 162,166 |
| Market Cap | 1.294B |
| Beta (5Y Monthly) | 0.81 |
| PE Ratio (TTM) | 38.33 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.
- Zacks
Dyne (DYN) Soars 28% on New Data From Muscle Disease Studies
Dyne (DYN) gains 28% after reporting positive new data from two separate ongoing mid to late-stage studies evaluating DYNE-101 and DYNE-251 for different muscle disease indications.
- Zacks
PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug
PTC Therapeutics (PTCT) gains 21% on May 20 after the EC decided against adopting the negative CHMP opinion of January 2024 on the annual renewal of the conditional approval of Translarna.
© 2024 Yahoo. All rights reserved.